AIMOVIG vs TRIJARDY XR

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Possible drug interaction. AIMOVIG and TRIJARDY XR are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AIMOVIG	TRIJARDY XR
Rating	72/100	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ERENUMAB-AOOE	EMPAGLIFLOZIN AND LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Manufacturer	Amgen Inc	Boehringer Ingelheim
Dosage forms	Injectable, Solution	Tablet, extended release
Drug class	—	—
Boxed warning	None	Boxed warning
Half-life	—	about 12 hours (apparent terminal elimination half-life ~12.4 h)

aimovig trijardy xr

Rating

72/100

Pharmacy pays

—

Type

Active ingredient

ERENUMAB-AOOE

EMPAGLIFLOZIN AND LINAGLIPTIN AND METFORMIN HYDROCHLORIDE

Manufacturer

Amgen Inc

Boehringer Ingelheim

Dosage forms

Injectable, Solution

Tablet, extended release

Drug class

—

Boxed warning

None

Boxed warning

Half-life

—

about 12 hours (apparent terminal elimination half-life ~12.4 h)

Frequently asked questions

Which is better-rated, Aimovig or Trijardy XR?

Aimovig and Trijardy XR are tied at 3.6 out of 5 by our independent rating.

What is the difference between Aimovig and Trijardy XR?

Aimovig contains Erenumab-Aooe, while Trijardy XR contains Empagliflozin and Linagliptin and Metformin Hydrochloride — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.